Comment from National Hispanic Medical Association

Summary: The National Hispanic Medical Association (NHMA) supports the FDA's graduated, risk-proportionate approach to evaluating flavored ENDS applications but urges the agency to make youth protection the primary threshold consideration. They advocate for the inclusion of health equity considerations for Latino and underserved communities, more rigorous scrutiny of industry-funded research, and the establishment of mandatory post-market surveillance and enforcement thresholds.